The International Society for Cell & Gene Therapy (ISCT) is delighted to announce the appointment of Phil Vanek, PhD, as the new ISCT Chief Commercialization Officer (CCO), effective January 1, 2025,… Read More
VANCOUVER, BC – Acuitas’ Chief Scientific Officer, Dr. Ying Tam, collaborated with scientists from the Children’s Hospital of Philadelphia and Perelman School of Medicine to determine whether messenger RNA lipid… Read More
JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years JOURNAVX is an effective… Read More
VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce that its common… Read More
BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine’s 2025 list of the World’s Most Admired Companies,™ a… Read More
